Biohaven (BHVN) reported a Q4 non-GAAP net loss of $1.71 per share, wider than its loss of $1.61 a year earlier.
Analysts polled by FactSet expected a loss of $1.49.
The company did not report any revenue for the quarter ended Dec. 31.
As of Dec. 31, the company said it had about $489 million in cash, cash equivalents, marketable securities and restricted cash.